This year, the Mitra Bio team will be presenting our latest findings at the Aging Research and Drug Discovery (ARDD) conference in Copenhagen.
Come to our main-stage talk
“Tracking skin health: non-invasive epigenetic biomarker proxies to assess intervention efficacy.”
Come learn about the pitfalls and challenges of measuring intervention efficacy for skin aging and how non-invasive skin epigenetic assays presents an interesting solution for this problem. Did you know existing gold standard epigenetic clocks don’t work well for the keratinocytes that make up your epidermis? Did you know epigenetic clocks and image-based techniques can suffer from reproducibility issues, giving widely different results each time? Learn how we have confronted these challenges and found promising solutions for skin aging clinical trials.
Thursday 28 August, 17:40–18:00 CET
Speaker: Cristiana Banila, PhD, Chief Scientific Officer
Book time with us at ARDD
If you work in skincare R&D or longevity therapeutics and are trying to:
- Substantiate anti-aging claims with molecular readouts
- Track intervention efficacy non-invasively in humans
- De-risk trials with reproducible methylation endpoints
Secure a time slot with us below to discuss your needs
